Skip to main content

Table 3 Surface under the cumulative ranking curve (SUCRA) values for recurrence

From: Network meta-analysis of adjuvant treatments for patients with hepatocellular carcinoma after curative resection

Treatment

SUCRA(%)

TACE + PVC

88.0

IRT

82.3

ERT

72.8

AIT

71.8

Huaier

59.4

HAIC

58.7

TACE

51.0

IFN

48.0

OCT

39.0

CIK

36.7

DC

30.7

BCAA

30.5

NA

23.4

SOR

7.8

  1. ERT External radiotherapy, BCAA Branched-chain amino acids, IRT Internal radiotherapy, HAIC Hepatic artery infusion chemotherapy, DC Dendritic cell, CIK Cytokine-induced killer, AIT Adoptive immunotherapy, IFN Interferon, OCT Oral chemotherapy, TACE Transcatheter arterial chemoembolization, PVC Portal vein chemotherapy, SOR Sorafenib, NA Non-adjuvant;
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us